Investor Relations Officer
Novartis – Basel

Relations with equity analysts and investors 

• establish and maintain professional relationships with sell-side and buy-side analysts and with investors, help them further deepen their understanding of Novartis data and Equity Story, answer their questions
• organize and conduct international roadshows, alone or with Executives
• present at bank conferences in plenary session or group meetings, alone or with Executives

Public speaking training for new spokespersons

• over 40 executives trained and prepared for public speaking in the context of IR activities, mostly Executive Committee members, and Heads of Franchises and Development Units, or large geographies
  
  
  • • specificities of financial communication in Pharma
    • market actors, and practical implications
    • legal context, DOs and DON’Ts
    • support development of key messages specific to each speaker in their respective role
    • rehearsal of questions and answers (Q&A) and of the Elevator pitch
    • live coaching on the road for the first event(s)

Training of new “IR contributors” to the IR function, its purpose and needs

• help IR Contributors (strategic assistant, project team leaders, franchise, communication …) understand the challenges and specific needs of the IR function (Q&A, slides, investors meetings …) at Novartis
• facilitate the integration of our new IR managers

Financial communication tools

• analyse and prepare external communication of partnership and M&A projects with biotechs (eg Alcon, AveXis, The Medicines Company, etc.)
• contribute to the preparation of press releases, Q&A, quarterly slide decks or newsflow related
• participate in the definition, organization and preparation of Capital Market Days

Scientific expertise

• acquire and develop IR required scientific and clinical knowledge with the Development and Medical teams, adapt it for Financial Communication purposes, and train the entire IR team on it
• attend key global medical congresses in relation to our franchises, engage with KOLs and presenters and obtain their perspectives on our and competitors data